PCN104 Cost Minimization Analysis (CMA) of Capecitabine/Cisplatin (XP) vs. 5-Fu/Cisplatin (FP) Regimens in Advanced Gastric Cancer (AGC) Treatment in the Romanian Setting

✍ Scribed by Curescu, S.; Stanculeanu, D.L.; Croitoru, A.; Radu, C.P.

• Book ID: 122193874
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 61 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.08.1205